D-0383-2026 Class II Ongoing

Recalled by The Harvard Drug Group LLC — Dublin, OH

FDA drug recall D-0383-2026 was initiated by The Harvard Drug Group LLC on Feb 17, 2026 and is designated Class II. Reason for recall: Defective container; inadequately sealed blister packaging. The recall status is ongoing. Affected quantity: 8892 cartons.

Recall details

Product Type
Drugs
Report Date
Mar 11, 2026
Initiation Date
Feb 17, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
8892 cartons

Product description

Midodrine Hydrochloride Tablets, USP, 5 mg, 50 Tablets (5 x 10 blister packs), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268 USA, NDC 0904-6818-06.

Reason for recall

Defective container; inadequately sealed blister packaging.

Distribution pattern

Nationwide US.

Code information

Lot # N02640, Exp Date: 08/2027

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0383-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0383-2026. Report a data issue: hello@regdatalab.com.